Nearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge - Takeaways - MDSpire

Nearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge

  • By

  • Juliette Cubanski

  • Nolan Sroczynski

  • June 29, 2026

  • 0 min

Share

  • 1

    The Medicare GLP-1 Bridge Program will begin on July 1, 2026, covering GLP-1s for weight management for eligible Medicare beneficiaries.

  • 2

    Approximately 3.8 million Medicare beneficiaries are estimated to meet the eligibility criteria for the Medicare GLP-1 Bridge in 2023.

  • 3

    Eligible beneficiaries must have a BMI of 35 or more or a BMI of 30 with specific comorbid conditions, excluding certain diagnoses.

  • 4

    The program will charge a $50 monthly copayment, which does not count towards the Part D deductible or out-of-pocket spending cap.

  • 5

    The total cost of the Medicare GLP-1 Bridge will depend on beneficiary participation rates, potentially ranging from $1.3 billion to $10 billion.

Original Source(s)

Nearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge

  • by Juliette Cubanski, Nolan Sroczynski

  • June 29, 2026

Related Content

GLP-1 Drugs Tied to Smell, Taste Changes

A matched electronic health record study of more than 876,000 patients with type 2 diabetes found a low absolute incidence but higher relative hazard of documented smell and taste disturbances among patients prescribed glucagon-like peptide-1 receptor agonists.

Correction: Mapping the Landscape of Perioperative Management in Metabolic and Bariatric Surgery: A Value-Complexity Framework-Guided Citespace Analysis

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.